Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Understanding hair surface properties is key for effective hair care products.

Some natural remedies may help with hair regrowth, but more research is needed to confirm their effectiveness and safety.

Some supplements and hormones can increase hair loss by raising DHT levels.

Technology enhances human design thinking, creating new possibilities.

Licorice has health benefits but can also cause side effects, so it should be used carefully.

HMPV causes respiratory infections, mainly managed with supportive care, and lacks a vaccine or specific treatment.

During the COVID-19 pandemic, dermatology visits decreased, especially among older patients, patients of color, men, and those with chronic conditions.

Microneedling, oral melatonin, trilostane, and deslorelin acetate implants are the best treatments for alopecia X in dogs.

Terbinafine is the most effective treatment for tinea capitis, a scalp infection often confused with other conditions.

Plant-based chemicals may help hair growth and prevent hair loss but need more research to compete with current treatments.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Nanotechnology shows promise for better drug delivery and cancer treatment.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Fullerenes show potential in skin care but need more safety research.

Fear of hair-related issues causes significant mental distress, especially in high-stress women.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Fat from the body can help improve hair growth and scars when used in skin treatments.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.